Latest news in cancer

Antibiotics can effectively prevent intestinal cancer metastasis
Researchers from Harvard University found evidence in a new study that colon cancer cells carry certain bacteria when they metastasize to other organs in the...
People group with a high risk of colorectal cancer
What is the disease of rectal cancer? Colorectal cancer is one of the five most common cancers in the world. The other four types of cancer are lung cancer,...
Should I start colorectal cancer screening at 45?
A new study reported at the European Digestive Disease Week (UEG) shows that regardless of family history, colorectal cancer screening has doubled since the...
Can cholera vaccine reduce the risk of death in colorectal cancer patients?
A Swedish study showed that vaccination with cholera after diagnosis of colorectal cancer can reduce the risk of colorectal cancer-related death and all-cause...
Chronic liver disease increases the risk of colorectal cancer
A systematic review and me of Sakuraba and other reports from the University of Chicagota analysis results show that patients with chronic liver disease have a...
Nuclear drugs to target and eliminate colorectal cancer
Researchers at Memorial Sloan Kettering Cancer Center and the Massachusetts Institute of Technology have developed a new three-step system that uses nuclear...
Fiber intake reduces mortality in patients with non-metastatic colorectal cancer
Mingyang Song of Harvard Medical School and Massachusetts General Hospital reported that after diagnosis of non-metastatic colorectal cancer, ingesting more...
Adding SIRT to chemotherapy can improve survival in colorectal cancer
Colorectal cancer The researchers found that adding SIRT to chemotherapy can improve the survival rate of colorectal cancer New research shows that for...
Stages of colon cancer
TNM staging system One tool doctors use to describe cancer staging is the TNM system. Doctors use the results of diagnostic tests and scans to answer the...
American Mayo Clinic experts talk about the treatment of rectal cancer
Rectal cancer is cancer that occurs in the last few inches of the colon. This area is called the rectum. The main treatment for rectal cancer is surgery....
Eating nuts is associated with a higher survival rate of colon cancer
 The 2017 Annual Meeting of the American Society of Oncology (ASCO) will be held in Chicago on June 2, local time. At 12 noon on May 17, local time, ASCO held...
Treatment strategy for oligometastatic advanced colorectal cancer
Treatment strategy in oligometastatic advanced colorectal cancer predominantly adopts a multi-modality approach including surgery and systemic therapy with...
Anti-PD-L1 immunotherapy combined with MEK inhibitor for metastatic colorectal cancer
At the 18th World Congress of Gastrointestinal Cancer, a phase I clinical study showed that anti-PD-L1 immunotherapy combined with MEK inhibitors can...
Application and evaluation of KRAS gene mutation method for colorectal cancer
Targeting drugs such as cetuximab and panitumumab have been widely used in clinic as effective therapeutic drugs for colorectal cancer. Clinical data show...
Lonsurf for the treatment of refractory metastatic colorectal cancer
Japanese pharmaceutical company Otsuka (Otsuka) recently received good news in the US regulatory aspects, FDA approved anti-cancer compound new drug Lo 3...
Leukemia treatment options
Because leukemia classification and prognosis stratification are complex, there is no one-size-fits-all treatment method, and it is necessary to combine...
Research progress in lymphoma
On June 17-20, 2015, the 13th International Lymphoma Conference was successfully held in Switzerland. 3700 representatives from 90 countries participated in...
MD Anderson cancer center treatment story of a leukemia patient
Eddle and Pearlie Saddler, as his wife Pearlie hopes, “enjoy a regular life” in their South Carolina town. When they rested, Saddlers volunteered...
PD-1 inhibitor immunotherapy for B cell lymphoma
A review written by Young, MD, Anderson Cancer Center, USA explained the application of PD-1 inhibitor immunotherapy in B-cell lymphoma. (Blood. Online...
Study finds new ideas for leukemia treatment
A new study from McMaster University in Canada said that it has discovered a new treatment strategy for acute myeloid leukemia. By stimulating the production...
Peripheral T-cell lymphoma faces challenges
The Cleveland Clinic of the United States Eric D. His et al. Reported that the diagnosis of peripheral T cell lymphoma (PTCL) in the United States varies...
AstraZeneca targeted drug Acalabrutinib has a new way to treat chronic lymphocytic leukemia
Acalabrutinib is a second-generation tyrosine kinase (BTK) inhibitor, a newer drug that can improve the survival of chronic lymphocytic leukemia (CLL) and...
Pathogenesis and treatment of mature T cell tumors
Mature T-cell tumors, such as non-Hodgkin T-cell lymphoma, are highly invasive and drug-resistant, and patients often have a poor prognosis. Recently,...
Can obesity cause cancer?
Obesity not only runs counter to the aesthetics of people, but also causes many chronic diseases. Some studies have shown that body mass index (BMI) is related...
Guideline for the treatment of mixed phenotype acute leukemia
A study conducted at the Los Angeles Children ’s Hospital is providing the best treatment for a rare invasive leukemia called mixed phenotype acute leukemia...
Treatment for advanced lymphoma
Yesterday, the US FDA announced the approval of Seattle Genetics’ antibody-drug conjugate Adcetris (brentuximab vedotin) in combination with chemotherapy...
This anticancer drug still benefits after 5 years of treatment for leukemia
According to the results of a 5-year follow-up of the key PACE trial published in the Journal of Hematology, panatinib (Ponatinib, Iclusig) has maintained...
Drugs for lymphoma leukemia to treat brain tumors
New Cleveland Clinic research shows for the first time that FDA-approved ibrutinib (ibrutinib) for lymphoma and leukemia may also help treat the most common...
First-line bosutinib is superior to imatinib in the treatment of leukemia
Bosutinib is a Src / Abl dual tyrosine kinase inhibitor approved for the treatment of newly diagnosed chronic phase (CP) chronic myelogenous leukemia (CML), or...
Lipid-lowering drugs are expected to assist in the treatment of leukemia
The latest research found that some statins can improve the efficacy of chemotherapy drugs used to treat blood cancer in mouse models. Statins are drugs that...
Can bone marrow fibrosis drugs induce lymphoma?
Bone marrow fibrosis is a rare chronic disease of bone marrow hematopoietic cells. They benefit from JAK2 inhibitor drugs: symptom relief, prolonged survival,...
Venetoclax therapy for leukemia
On June 8 , the US FDA approved Venetoclax ( VENCLEXTA , AbbVie Inc. and Genentech Inc. ) for patients with chronic lymphocytic leukemia ( CLL ) or small...
Lymphoma: Pembrolizumab treatment approved
On June 12-13, FDA approved two new indications for K drug, just the day before the K drug was approved for the treatment of cervical cancer. One day later,...
Researchers discover a new mechanism of lymphoma resistance
In the United States, more than 70,000 people are diagnosed with non-Hodgkin’s lymphoma each year, which is caused by excessive proliferation of immune...
Progress in lymphoma immunotherapy
In recent years, the effect of immune checkpoint inhibitors on the treatment of Hodgkin’s lymphoma (HL) is impressive, but the disease still needs to be...
Genetic research solves 30-year leukemia mystery
Researchers at the University of California, San Francisco and St. Jude Children ’s Research Hospital in Tennessee have solved medical mysteries decades ago,...

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

Scan the code